Medical Journals

Kinetic Characterization of Recombinant Human Acidic Mammalian Chitinase.

Authors:
  • Chou Yi-Te
  • Yao Shihua
  • Czerwinski Robert
  • Fleming Margaret
  • Krykbaev Rustem
  • Xuan Dejun
  • Zhou Huanfang
  • Brooks Jonathan
  • Fitz Lori
  • Strand James
  • Presman Eleonora
  • Lin Laura
  • Aulabaugh Ann
  • Huang Xinyi

From: Department of Chemical and Screening Sciences, Wyeth Research, 500 Arcola Road, Collegeville, Pennsylvania 19426, USA.

Biochemistry

  • Publish Date: Apr 2006
  • ISSN: 0006-2960
  • Volume: 45
  • Issue: 14
  • Pages: 4444-54
  • Medium: Print
  • Language: English
  • Citation (JAMA): Chou Yi-Te, Yao Shihua, Czerwinski Robert, et al. Kinetic Characterization of Recombinant Human Acidic Mammalian Chitinase.. Biochemistry Apr 2006;45:4444-54

Abstract

Human acidic mammalian chitinase (AMCase), a member of the family 18 glycosyl hydrolases, is one of the important proteins involved in Th2-mediated inflammation and has been implicated in asthma and allergic diseases. Inhibition of AMCase results in decreased airway inflammation and airway hyper-responsiveness in a mouse asthma model, suggesting that the AMCase activity is a part of the mechanism of Th2 cytokine-driven inflammatory response in asthma. In this paper, we report the first detailed kinetic characterization of recombinant human AMCase. In contrast with mouse AMCase that has been reported to have a major pH optimum at 2 and a secondary pH optimum around 3-6, human AMCase has only one pH optimum for k(cat)/K(m) between pH 4 and 5. Steady state kinetics shows that human AMCase has “low” intrinsic transglycosidase activity, which leads to the observation of apparent substrate inhibition. This slow transglycosylation may provide a mechanism in vivo for feedback regulation of the chitinase activity of human AMCase. HPLC characterization of cleavage of chitooligosaccharides (4-6-mers) suggests that human AMCase prefers the beta anomer of chitooligosaccharides as substrate. Human AMCase also appears to cleave chitooligosaccharides from the nonreducing end primarily by disaccharide units. Ionic strength modulates the enzymatic activity and substrate cleavage pattern of human AMCase against fluorogenic substrates, chitobiose-4-methylumbelliferyl and chitotriose-4-methylumbelliferyl, and enhances activity against chitooligosaccharides. The physiological implications of these results are discussed.

Mesh Headings (Keywords): Animals, CHO Cells, Chitinase, Cricetinae, Cricetulus, Humans, Hydrogen-Ion Concentration, Kinetics, Osmolar Concentration, Recombinant Proteins


Check for Full Text / PubMed Unique Identifier (PMID): 16584180


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.